Nakagawa F, Palich R, Kall M, Sewell J, Smith C, Kelly C, Kitt H, Pelchen-Matthews A, Aghaizu A, Sparrowhawk A, Mackie N, Djuretic T, Schoeman S, Humphreys C, Lipman M, Lampe F C, Rodger A J
Institute for Global Health, University College London, London, UK.
UK Health Security Agency, London, UK.
HIV Med. 2025 Jun;26(6):923-939. doi: 10.1111/hiv.70026. Epub 2025 May 1.
We assessed the impact of COVID-19, and the prevalence and factors associated with a history of COVID-19 infection, long COVID and incomplete COVID-19 vaccine uptake among people with HIV.
Positive Voices 2022 is a questionnaire study of people accessing HIV care in the United Kingdom (March 2022-April 2023). Logistic regression assessed factors associated with a history of COVID-19 (previous positive test), long COVID among those with a history of COVID-19 (ongoing symptoms, with COVID-19 onset >3 months previously) and incomplete COVID-19 vaccine uptake (less than three doses of vaccine), adjusted for: age; gender; ethnicity; and year of HIV diagnosis.
In all, 4188 participants were included. Commonly reported negative impacts of the pandemic were on social contact (44% of participants), mental health (30%), healthcare access (26%) and financial security (25%). Overall, 2068 of 4188 (49.4%) participants had a history of COVID-19. Of these, 10.8% met criteria for long COVID, associated with female gender, unemployment, financial hardship, earlier HIV diagnosis date, diabetes diagnosis, asthma/chronic obstructive pulmonary disease diagnosis, obesity and symptoms of depression and anxiety. Overall, 95.8% reported having at least one vaccine dose, but 649 (15.7%) participants had incomplete vaccine uptake, associated with younger age, female gender, Black African ethnicity, lower education, financial hardship, unemployment, multioccupancy household, more recent HIV diagnosis, detectable HIV viral load and symptoms of depression and anxiety.
About half of participants had a history of COVID-19, of whom 11% had persistent symptoms (long COVID). COVID-19 vaccine uptake was high, but incomplete uptake was apparent for 16% of participants and was more common among women, younger people, Black African individuals and those with socio-economic disadvantage.
我们评估了2019冠状病毒病(COVID-19)的影响,以及HIV感染者中COVID-19感染史、长期COVID-19和COVID-19疫苗接种不完全的患病率及相关因素。
“积极之声2022”是一项针对在英国接受HIV治疗的人群的问卷调查研究(2022年3月至2023年4月)。逻辑回归分析评估了与COVID-19感染史(既往检测呈阳性)、有COVID-19感染史者的长期COVID-19(持续症状,COVID-19发病时间超过3个月)和COVID-19疫苗接种不完全(疫苗接种少于三剂)相关的因素,并对年龄、性别、种族和HIV诊断年份进行了校正。
共纳入4188名参与者。普遍报告的疫情负面影响涉及社交联系(44%的参与者)、心理健康(30%)、医疗服务获取(26%)和财务安全(25%)。总体而言,4188名参与者中有2068名(49.4%)有COVID-19感染史。其中,10.8%符合长期COVID-19标准,与女性、失业、经济困难、HIV诊断日期较早、糖尿病诊断、哮喘/慢性阻塞性肺疾病诊断、肥胖以及抑郁和焦虑症状有关。总体而言,95.8%的参与者报告至少接种了一剂疫苗,但649名(15.7%)参与者疫苗接种不完全,这与年龄较小、女性、非洲黑人种族、教育程度较低、经济困难、失业、多人合住家庭、HIV诊断较晚、可检测到的HIV病毒载量以及抑郁和焦虑症状有关。
约一半的参与者有COVID-19感染史,其中11%有持续症状(长期COVID-19)。COVID-19疫苗接种率较高,但16%的参与者存在接种不完全的情况,在女性、年轻人、非洲黑人个体以及社会经济处于劣势的人群中更为常见。